Harnessing the inherent anti-spoofing quality from electroencephalogram (EEG) signals has become a potential field of research in recent years. Although several studies have been conducted, still there are some vital challenges present in the deployment of EEG-based biometrics, which is stable and capable of handling the real-world scenario. One of the key challenges is the large signal variability of EEG when recorded on different days or sessions which impedes the performance of biometric systems significantly. To address this issue, a session invariant multimodal Self-organized Operational Neural Network (Self-ONN) based ensemble model combining EEG and keystroke dynamics is proposed in this paper. Our model is tested successfully on a large number of sessions (10 recording days) with many challenging noisy and variable environments for the identification and authentication tasks. In most of the previous studies, training and testing were performed either over a single recording session (same day) only or without ensuring appropriate splitting of the data on multiple recording days. Unlike those studies, in our work, we have rigorously split the data so that train and test sets do not share the data of the same recording day. The proposed multimodal Self-ONN based ensemble model has achieved identification accuracy of 98% in rigorous validation cases and outperformed the equivalent ensemble of deep CNN models. A novel Self-ONN Siamese network has also been proposed to measure the similarity of templates during the authentication task instead of the commonly used simple distance measure techniques. The multimodal Siamese network reduces the Equal Error Rate (EER) to 1.56% in rigorous authentication. The obtained results indicate that the proposed multimodal Self-ONN model can automatically extract session invariant unique non-linear features to identify and authenticate users with high accuracy.
Cardiovascular diseases are the most common causes of death around the world. To detect and treat heart-related diseases, continuous blood pressure (BP) monitoring along with many other parameters are required. Several invasive and non-invasive methods have been developed for this purpose. Most existing methods used in hospitals for continuous monitoring of BP are invasive. On the contrary, cuff-based BP monitoring methods, which can predict systolic blood pressure (SBP) and diastolic blood pressure (DBP), cannot be used for continuous monitoring. Several studies attempted to predict BP from non-invasively collectible signals such as photoplethysmograms (PPG) and electrocardiograms (ECG), which can be used for continuous monitoring. In this study, we explored the applicability of autoencoders in predicting BP from PPG and ECG signals. The investigation was carried out on 12,000 instances of 942 patients of the MIMIC-II dataset, and it was found that a very shallow, one-dimensional autoencoder can extract the relevant features to predict the SBP and DBP with state-of-the-art performance on a very large dataset. An independent test set from a portion of the MIMIC-II dataset provided a mean absolute error (MAE) of 2.333 and 0.713 for SBP and DBP, respectively. On an external dataset of 40 subjects, the model trained on the MIMIC-II dataset provided an MAE of 2.728 and 1.166 for SBP and DBP, respectively. For both the cases, the results met British Hypertension Society (BHS) Grade A and surpassed the studies from the current literature.
The coronavirus disease 2019 (COVID-19) after outbreaking in Wuhan increasingly spread throughout the world. Fast, reliable, and easily accessible clinical assessment of the severity of the disease can help in allocating and prioritizing resources to reduce mortality. The objective of the study was to develop and validate an early scoring tool to stratify the risk of death using readily available complete blood count (CBC) biomarkers. A retrospective study was conducted on twenty-three CBC blood biomarkers for predicting disease mortality for 375 COVID-19 patients admitted to Tongji Hospital, China from January 10 to February 18, 2020. Machine learning based key biomarkers among the CBC parameters as the mortality predictors were identified. A multivariate logistic regression-based nomogram and a scoring system was developed to categorize the patients in three risk groups (low, moderate, and high) for predicting the mortality risk among COVID-19 patients. Lymphocyte count, neutrophils count, age, white blood cell count, monocytes (%), platelet count, red blood cell distribution width parameters collected at hospital admission were selected as important biomarkers for death prediction using random forest feature selection technique. A CBC score was devised for calculating the death probability of the patients and was used to categorize the patients into three sub-risk groups: low (<=5%), moderate (>5% and <=50%), and high (>50%), respectively. The area under the curve (AUC) of the model for the development and internal validation cohort were 0.961 and 0.88, respectively. The proposed model was further validated with an external cohort of 103 patients of Dhaka Medical College, Bangladesh, which exhibits in an AUC of 0.963. The proposed CBC parameter-based prognostic model and the associated web-application, can help the medical doctors to improve the management by early prediction of mortality risk of the COVID-19 patients in the low-resource countries.